Fresenius Medical Care AG ADR FMS
News
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
